Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
The Lancet (British edition), 2008-07, Vol.372 (9634), p.216-223 [Peer Reviewed Journal]Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(08)61075-2
Full text available